Retractable Technologies (NYSE:RVP) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research report released on Thursday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Price Performance

Shares of Retractable Technologies stock opened at $0.76 on Thursday. The stock’s 50-day moving average is $0.89 and its 200 day moving average is $1.03. Retractable Technologies has a one year low of $0.71 and a one year high of $1.34. The firm has a market cap of $22.72 million, a price-to-earnings ratio of -1.24 and a beta of 2.06. The company has a debt-to-equity ratio of 0.01, a current ratio of 9.51 and a quick ratio of 6.54.

Retractable Technologies (NYSE:RVP) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. The business had revenue of $6.03 million for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%.

Insider Buying and Selling at Retractable Technologies

In related news, CEO Thomas J. Shaw acquired 71,422 shares of the business’s stock in a transaction dated Friday, September 20th. The shares were bought at an average price of $0.82 per share, with a total value of $58,566.04. Following the transaction, the chief executive officer now directly owns 14,743,907 shares of the company’s stock, valued at $12,090,003.74. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Over the last ninety days, insiders purchased 182,128 shares of company stock valued at $166,565. Corporate insiders own 55.00% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.